Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 446

1.

Intratumoral delivery of an adenoviral vector carrying the SOCS-1 gene enhances T cell-mediated anti-tumor immunity by suppressing PD-L1.

Nakagawa S, Serada S, Kakubari R, Hiramatsu K, Sugase T, Matsuzaki S, Matsuzaki S, Ueda Y, Yoshino K, Ohkawara T, Fujimoto M, Kishimoto T, Kimura T, Naka T.

Mol Cancer Ther. 2018 Jun 11. pii: molcanther.0822.2017. doi: 10.1158/1535-7163.MCT-17-0822. [Epub ahead of print]

PMID:
29891489
2.

Requirement of the 3'-UTR-dependent suppression of DAZL in oocytes for pre-implantation mouse development.

Fukuda K, Masuda A, Naka T, Suzuki A, Kato Y, Saga Y.

PLoS Genet. 2018 Jun 8;14(6):e1007436. doi: 10.1371/journal.pgen.1007436. eCollection 2018 Jun.

3.

Final Results of the OPERA Experiment on ν_{τ} Appearance in the CNGS Neutrino Beam.

Agafonova N, Alexandrov A, Anokhina A, Aoki S, Ariga A, Ariga T, Bertolin A, Bozza C, Brugnera R, Buonaura A, Buontempo S, Chernyavskiy M, Chukanov A, Consiglio L, D'Ambrosio N, De Lellis G, De Serio M, Del Amo Sanchez P, Di Crescenzo A, Di Ferdinando D, Di Marco N, Dmitrievsky S, Dracos M, Duchesneau D, Dusini S, Dzhatdoev T, Ebert J, Ereditato A, Favier J, Fini RA, Fornari F, Fukuda T, Galati G, Garfagnini A, Gentile V, Goldberg J, Gorbunov S, Gornushkin Y, Grella G, Guler AM, Gustavino C, Hagner C, Hara T, Hayakawa T, Hollnagel A, Ishiguro K, Iuliano A, Jakovcic K, Jollet C, Kamiscioglu C, Kamiscioglu M, Kim SH, Kitagawa N, Klicek B, Kodama K, Komatsu M, Kose U, Kreslo I, Laudisio F, Lauria A, Ljubicic A, Longhin A, Loverre P, Malenica M, Malgin A, Mandrioli G, Matsuo T, Matveev V, Mauri N, Medinaceli E, Meregaglia A, Mikado S, Miyanishi M, Mizutani F, Monacelli P, Montesi MC, Morishima K, Muciaccia MT, Naganawa N, Naka T, Nakamura M, Nakano T, Niwa K, Ogawa S, Okateva N, Olchevsky A, Ozaki K, Paoloni A, Paparella L, Park BD, Pasqualini L, Pastore A, Patrizii L, Pessard H, Pistillo C, Podgrudkov D, Polukhina N, Pozzato M, Pupilli F, Roda M, Roganova T, Rokujo H, Rosa G, Ryazhskaya O, Sadovsky A, Sato O, Schembri A, Shakiryanova I, Shchedrina T, Shibayama E, Shibuya H, Shiraishi T, Simone S, Sirignano C, Sirri G, Sotnikov A, Spinetti M, Stanco L, Starkov N, Stellacci SM, Stipcevic M, Strolin P, Takahashi S, Tenti M, Terranova F, Tioukov V, Tufanli S, Ustyuzhanin A, Vasina S, Vilain P, Voevodina E, Votano L, Vuilleumier JL, Wilquet G, Wonsak B, Yoon CS; OPERA Collaboration.

Phys Rev Lett. 2018 May 25;120(21):211801. doi: 10.1103/PhysRevLett.120.211801.

PMID:
29883136
4.

SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling.

Sugase T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hiramatsu K, Nishida T, Hirota S, Saito Y, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Hanasaki K, Kishimoto T, Mori M, Doki Y, Naka T.

Gastric Cancer. 2018 Apr 5. doi: 10.1007/s10120-018-0822-1. [Epub ahead of print]

PMID:
29623544
5.

Re-infection of Toxoplasma gondii after HSCT presenting lymphadenopathy resembling recurrence of lymphoma.

Hashiguchi J, Onozawa M, Naka T, Hatanaka KC, Shiratori S, Sugita J, Fujimoto K, Matsuno Y, Teshima T.

Transpl Infect Dis. 2018 Jun;20(3):e12892. doi: 10.1111/tid.12892. Epub 2018 Apr 19.

PMID:
29603522
6.

Leucine rich α-2 glycoprotein is a potential urinary biomarker for renal tubular injury.

Lee H, Fujimoto M, Ohkawara T, Honda H, Serada S, Terada Y, Naka T.

Biochem Biophys Res Commun. 2018 Apr 15;498(4):1045-1051. doi: 10.1016/j.bbrc.2018.03.111. Epub 2018 Mar 17.

PMID:
29550485
7.

Spontaneous reduction of native kidney size involving angiomyolipoma lesions in a kidney transplant recipient with tuberous sclerosis complex.

Sasaki H, Iwami D, Hotta K, Morita K, Naka T, Shinohara N.

Int J Urol. 2018 May;25(5):513-514. doi: 10.1111/iju.13534. Epub 2018 Feb 8. No abstract available.

PMID:
29417638
8.

Leucine-rich α-2 glycoprotein promotes lung fibrosis by modulating TGF-β signaling in fibroblasts.

Honda H, Fujimoto M, Serada S, Urushima H, Mishima T, Lee H, Ohkawara T, Kohno N, Hattori N, Yokoyama A, Naka T.

Physiol Rep. 2017 Dec;5(24). pii: e13556. doi: 10.14814/phy2.13556. Epub 2017 Dec 26.

9.

Characteristics of upper-limb pull power and power endurance in Japanese female wrestlers.

Naka T, Kanno M, Shidochi S, Sakae K, Shima N.

J Strength Cond Res. 2017 Nov 22. doi: 10.1519/JSC.0000000000002378. [Epub ahead of print]

PMID:
29210895
10.

LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.

Hiramatsu K, Serada S, Enomoto T, Takahashi Y, Nakagawa S, Nojima S, Morimoto A, Matsuzaki S, Yokoyama T, Takahashi T, Fujimoto M, Takemori H, Ueda Y, Yoshino K, Morii E, Kimura T, Naka T.

Cancer Res. 2018 Jan 15;78(2):516-527. doi: 10.1158/0008-5472.CAN-17-0910. Epub 2017 Nov 29.

PMID:
29187404
11.

Surgically Diagnosed Primary Hepatic Angiosarcoma.

Tsunematsu S, Muto S, Oi H, Naka T, Kitagataya T, Sasaki R, Taya Y, Baba U, Tsukamoto Y, Uemura K, Kimura T, Ohara Y.

Intern Med. 2018 Mar 1;57(5):687-691. doi: 10.2169/internalmedicine.9318-17. Epub 2017 Nov 20.

12.

Prevalence and associated factors of foot and ankle pain among nurses at a university hospital in Japan: A cross-sectional study.

Tojo M, Yamaguchi S, Amano N, Ito A, Futono M, Sato Y, Naka T, Kimura S, Sadamasu A, Akagi R, Ohtori S.

J Occup Health. 2018 Mar 27;60(2):132-139. doi: 10.1539/joh.17-0174-OA. Epub 2017 Nov 18.

13.

Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.

Matsuzaki S, Serada S, Hiramatsu K, Nojima S, Matsuzaki S, Ueda Y, Ohkawara T, Mabuchi S, Fujimoto M, Morii E, Yoshino K, Kimura T, Naka T.

Int J Cancer. 2018 Mar 1;142(5):1056-1066. doi: 10.1002/ijc.31124. Epub 2017 Oct 31.

PMID:
29055044
14.

SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma.

Sugase T, Takahashi T, Serada S, Fujimoto M, Hiramatsu K, Ohkawara T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Kishimoto T, Mori M, Doki Y, Naka T.

Cancer Res. 2017 Dec 15;77(24):6975-6986. doi: 10.1158/0008-5472.CAN-17-1525. Epub 2017 Oct 17.

PMID:
29042418
15.

Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system.

Sumi-Akamaru H, Eto M, Yamauchi A, Uehara T, Kakuda K, Obayashi K, Kato S, Naka T, Mochizuki H.

Neuropathology. 2018 Feb;38(1):11-21. doi: 10.1111/neup.12412. Epub 2017 Sep 28.

PMID:
28960480
16.

Case Report: Pulmonary Tumor Thrombotic Microangiopathy in a Cervical Cancer Patient.

Tsujimoto N, Miyoshi A, Mimura M, Naka T, Yamasaki M, Yokoi T.

Gynecol Obstet Invest. 2018;83(1):99-104. doi: 10.1159/000480400. Epub 2017 Sep 7.

PMID:
28877521
17.

Overexpression of leucine-rich α2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer.

Yamamoto M, Takahashi T, Serada S, Sugase T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Naka T, Mori M, Doki Y.

Cancer Sci. 2017 Oct;108(10):2052-2060. doi: 10.1111/cas.13329.

18.
19.

Transition-Metal-Free and Oxidant-Free Cross-Coupling of Arylhydrazines with Disulfides: Base-Promoted Synthesis of Unsymmetrical Aryl Sulfides.

Taniguchi T, Naka T, Imoto M, Takeda M, Nakai T, Mihara M, Mizuno T, Nomoto A, Ogawa A.

J Org Chem. 2017 Jul 7;82(13):6647-6655. doi: 10.1021/acs.joc.7b00767. Epub 2017 Jun 23.

PMID:
28616985
20.

Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-β-Smad2 signaling in naïve helper T cells.

Urushima H, Fujimoto M, Mishima T, Ohkawara T, Honda H, Lee H, Kawahata H, Serada S, Naka T.

Arthritis Res Ther. 2017 Jun 14;19(1):137. doi: 10.1186/s13075-017-1349-2.

21.

Extra-Articular Tenosynovial Chondromatosis of the Finger: A Case Series Study of Three Cases, One Including Excessive Osseous Invasion.

Sakamoto A, Naka T, Shiba E, Hisaoka M, Matsuda S.

Open Orthop J. 2017 May 17;11:417-423. doi: 10.2174/1874325001711010417. eCollection 2017.

22.

Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma.

Harada E, Serada S, Fujimoto M, Takahashi Y, Takahashi T, Hara H, Nakatsuka R, Sugase T, Nishigaki T, Saito Y, Hiramatsu K, Nojima S, Mitsuo R, Ohkawara T, Morii E, Mori M, Doki Y, Kaneda Y, Naka T.

Oncotarget. 2017 Apr 11;8(15):24741-24752. doi: 10.18632/oncotarget.15799.

23.

A novel pathogenesis of inflammatory bowel disease from the perspective of glyco-immunology.

Shinzaki S, Iijima H, Fujii H, Kamada Y, Naka T, Takehara T, Miyoshi E.

J Biochem. 2017 May 1;161(5):409-415. doi: 10.1093/jb/mvx010.

PMID:
28338836
24.

Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.

Sugase T, Takahashi T, Serada S, Nakatsuka R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Kishimoto T, Mori M, Doki Y, Naka T.

Int J Cancer. 2017 Jun 1;140(11):2608-2621. doi: 10.1002/ijc.30666. Epub 2017 Mar 10.

25.

Optimization of T1-weighted Imaging Parameters in MR Carotid Plaque Imaging: Influence for the Quantitative Evaluation among Different MRI Scanner Types.

Naka T, Takahashi M, Takeda K, Igarashi T, Hondera T.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(2):104-111. doi: 10.6009/jjrt.2017_JSRT_73.2.104. Japanese.

26.

Leucine-rich α-2 glycoprotein is an innovative biomarker for psoriasis.

Nakajima H, Serada S, Fujimoto M, Naka T, Sano S.

J Dermatol Sci. 2017 May;86(2):170-174. doi: 10.1016/j.jdermsci.2017.01.008. Epub 2017 Jan 29. No abstract available.

PMID:
28179066
27.

Genomic and transcriptomic analysis of imatinib resistance in gastrointestinal stromal tumors.

Takahashi T, Elzawahry A, Mimaki S, Furukawa E, Nakatsuka R, Nakamura H, Nishigaki T, Serada S, Naka T, Hirota S, Shibata T, Tsuchihara K, Nishida T, Kato M.

Genes Chromosomes Cancer. 2017 Apr;56(4):303-313. doi: 10.1002/gcc.22438. Epub 2017 Jan 23.

28.

Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody.

Hosono Y, Nakashima R, Serada S, Murakami K, Imura Y, Yoshifuji H, Ohmura K, Naka T, Mimori T.

J Autoimmun. 2017 Feb;77:116-122. doi: 10.1016/j.jaut.2016.11.006. Epub 2016 Dec 3.

PMID:
27919567
29.

Development of fast neutron pinhole camera using nuclear emulsion for neutron emission profile measurement in KSTAR.

Izumi Y, Tomita H, Nakayama Y, Hayashi S, Morishima K, Isobe M, Cheon MS, Ogawa K, Nishitani T, Naka T, Nakano T, Nakamura M, Iguchi T.

Rev Sci Instrum. 2016 Nov;87(11):11D840.

PMID:
27910454
30.
31.

Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.

Shinzaki S, Matsuoka K, Iijima H, Mizuno S, Serada S, Fujimoto M, Arai N, Koyama N, Morii E, Watanabe M, Hibi T, Kanai T, Takehara T, Naka T.

J Crohns Colitis. 2017 Jan;11(1):84-91. doi: 10.1093/ecco-jcc/jjw132. Epub 2016 Jul 27.

32.

An autopsy case of leptomeningeal amyloidosis associated with transthyretin Gly47Arg mutation.

Uehara T, Kakuda K, Sumi-Akamaru H, Yamauchi A, Mochizuki H, Naka T.

Rinsho Shinkeigaku. 2016 Nov 29;56(11):777-780. Epub 2016 Oct 26. Japanese.

PMID:
27784877
33.

Effects of high-intensity swimming training on the bones of ovariectomized rats.

Oh T, Tanaka S, Naka T, Igawa S.

J Exerc Nutrition Biochem. 2016 Sep;20(3):39-45. Epub 2016 Sep 30.

34.

The assassin bug genera Nagustoides and Stenolemus (Hemiptera: Heteroptera: Reduviidae) newly recorded from Japan.

Ishikawa T, Naka T.

Zootaxa. 2016 Sep 7;4161(4):593-600. doi: 10.11646/zootaxa.4161.4.12.

PMID:
27615956
35.

Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma.

Honda H, Fujimoto M, Miyamoto S, Ishikawa N, Serada S, Hattori N, Nomura S, Kohno N, Yokoyama A, Naka T.

PLoS One. 2016 Sep 9;11(9):e0162672. doi: 10.1371/journal.pone.0162672. eCollection 2016.

36.

Real-time observations of lithium battery reactions-operando neutron diffraction analysis during practical operation.

Taminato S, Yonemura M, Shiotani S, Kamiyama T, Torii S, Nagao M, Ishikawa Y, Mori K, Fukunaga T, Onodera Y, Naka T, Morishima M, Ukyo Y, Adipranoto DS, Arai H, Uchimoto Y, Ogumi Z, Suzuki K, Hirayama M, Kanno R.

Sci Rep. 2016 Jun 30;6:28843. doi: 10.1038/srep28843.

37.

Rotational symmetry breaking in the topological superconductor SrxBi2Se3 probed by upper-critical field experiments.

Pan Y, Nikitin AM, Araizi GK, Huang YK, Matsushita Y, Naka T, de Visser A.

Sci Rep. 2016 Jun 28;6:28632. doi: 10.1038/srep28632.

38.

Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.

Hara H, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Nakatsuka R, Harada E, Nishigaki T, Takahashi Y, Nojima S, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Morii E, Mori M, Doki Y, Naka T.

Br J Cancer. 2016 Jun 28;115(1):66-75. doi: 10.1038/bjc.2016.183. Epub 2016 Jun 16.

39.

Composition induced metal-insulator quantum phase transition in the Heusler type Fe2VAl.

Naka T, Nikitin AM, Pan Y, de Visser A, Nakane T, Ishikawa F, Yamada Y, Imai M, Matsushita A.

J Phys Condens Matter. 2016 Jul 20;28(28):285601. doi: 10.1088/0953-8984/28/28/285601. Epub 2016 May 24.

PMID:
27218143
40.

Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.

Naka T, Hatanaka Y, Marukawa K, Okada H, Hatanaka KC, Sakakibara-Konishi J, Oizumi S, Hida Y, Kaga K, Mitsuhashi T, Matsuno Y.

Diagn Pathol. 2016 Apr 18;11:38. doi: 10.1186/s13000-016-0488-0.

41.

Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.

Han Y, Ripley B, Serada S, Naka T, Fujimoto M.

PLoS One. 2016 Apr 12;11(4):e0153399. doi: 10.1371/journal.pone.0153399. eCollection 2016.

42.

Unusual case of tacrolimus vascular toxicity after deceased donor renal transplantation.

Sugitani A, Takahashi C, Naka T, Hisamitsu K, Yamamoto O, Taniguchi K, Kobayashi N, Kimura M, Yoshida H, Hamazoe R.

Nephrology (Carlton). 2016 Jul;21 Suppl 1:60-2. doi: 10.1111/nep.12783.

PMID:
27004749
43.

Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas.

Hiramatsu K, Yoshino K, Serada S, Yoshihara K, Hori Y, Fujimoto M, Matsuzaki S, Egawa-Takata T, Kobayashi E, Ueda Y, Morii E, Enomoto T, Naka T, Kimura T.

Br J Cancer. 2016 Mar 1;114(5):554-61. doi: 10.1038/bjc.2016.27. Epub 2016 Feb 18.

44.

Cell surface localization of importin α1/KPNA2 affects cancer cell proliferation by regulating FGF1 signalling.

Yamada K, Miyamoto Y, Tsujii A, Moriyama T, Ikuno Y, Shiromizu T, Serada S, Fujimoto M, Tomonaga T, Naka T, Yoneda Y, Oka M.

Sci Rep. 2016 Feb 18;6:21410. doi: 10.1038/srep21410.

45.

Large-scale proteome analysis of abscisic acid and ABSCISIC ACID INSENSITIVE3-dependent proteins related to desiccation tolerance in Physcomitrella patens.

Yotsui I, Serada S, Naka T, Saruhashi M, Taji T, Hayashi T, Quatrano RS, Sakata Y.

Biochem Biophys Res Commun. 2016 Mar 18;471(4):589-95. doi: 10.1016/j.bbrc.2016.02.024. Epub 2016 Feb 8.

PMID:
26869511
46.

Increased serum CXCR2 ligand levels in livedo vasculopathy with winter ulcerations: Possible contribution of neutrophil recruitment to lesional skin.

Yang L, Murota H, Shindo S, Yang F, Serada S, Fujimoto M, Naka T, Katayama I.

J Dermatol Sci. 2016 Apr;82(1):57-9. doi: 10.1016/j.jdermsci.2016.01.004. Epub 2016 Jan 8. No abstract available.

PMID:
26827264
47.

Detecting Secondary C-KIT Mutations in the Peripheral Blood of Patients with Imatinib-Resistant Gastrointestinal Stromal Tumor.

Wada N, Kurokawa Y, Takahashi T, Hamakawa T, Hirota S, Naka T, Miyazaki Y, Makino T, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y.

Oncology. 2016;90(2):112-7. doi: 10.1159/000442948. Epub 2016 Jan 19.

PMID:
26779618
48.

Human herpesvirus 6 U11 protein is critical for virus infection.

Mahmoud NF, Kawabata A, Tang H, Wakata A, Wang B, Serada S, Naka T, Mori Y.

Virology. 2016 Feb;489:151-7. doi: 10.1016/j.virol.2015.12.011. Epub 2016 Jan 4.

49.

Myeloid cell-derived LRG attenuates adverse cardiac remodelling after myocardial infarction.

Kumagai S, Nakayama H, Fujimoto M, Honda H, Serada S, Ishibashi-Ueda H, Kasai A, Obana M, Sakata Y, Sawa Y, Fujio Y, Naka T.

Cardiovasc Res. 2016 Feb 1;109(2):272-82. doi: 10.1093/cvr/cvv273. Epub 2015 Dec 17.

PMID:
26678356
50.

Cardiac fibroma with high 18F-FDG uptake mimicking malignant tumor.

Masuda A, Manabe O, Oyama-Manabe N, Naya M, Obara M, Sakakibara M, Hirata K, Yamada S, Naka T, Tsutsui H, Tamaki N.

J Nucl Cardiol. 2017 Feb;24(1):323-324. doi: 10.1007/s12350-015-0362-6. Epub 2015 Dec 16. No abstract available.

PMID:
26676029

Supplemental Content

Support Center